Close Menu

NEW YORK (360Dx) – Clinical Genomics and Quest Diagnostics today announced a five-year extension to a US supply agreement for the InSure One fecal immunochemical test (FIT).

Clinical Genomics manufacturers FIT tests, including InSure One FIT. Under the supply agreement extension, Quest will continue to provide the tests to physicians and organized provider groups across the US, including specialized programs to improve colorectal cancer screening rates for accountable care organizations and other organizations focused on value-based care models.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.